In vivo SPECT imaging of vesicular acetylcholine transporter using [123I]-IBVM in early Alzheimer's disease

作者: J. Mazère , C. Prunier , O. Barret , M. Guyot , C. Hommet

DOI: 10.1016/J.NEUROIMAGE.2007.11.028

关键词: Vesicular acetylcholine transporterCholinergic neuronMedicineAtrophySingle-photon emission computed tomographyStatistical parametric mappingNuclear medicineCholinergicSpect imagingMagnetic resonance imaging

摘要: Abstract Introduction Little is known about cholinergic activity in the early stage of Alzheimer's disease. We investigated differences distribution vesicular acetylcholine transporter, using [ 123 I]-iodobenzovesamicol ([ I]-IBVM) and Single Photon Computed Tomography (SPECT), AD age-matched controls. Materials methods Sixteen subjects (8 controls, 8 AD) underwent I]-IBVM SPECT scanning, T1-weighted anatomic scan by Magnetic Resonance (MR) imaging Mini-Mental State Evaluation (MMSE). Image analysis, Statistical Parametric Mapping (SPM 02), involved coregistration each image to MR scan, followed a spatial normalisation Montreal Neurological Institute standard brain smoothing image. Group effects correlation were assessed two sample t -tests linear regression respectively. Atrophy difference between groups was voxel-based morphometry -tests. Results MMSE values significantly different Relative significant decrease binding (47–62%) apparent cingulate cortex parahippocampal–amygdaloid complex. These patterns appeared be independent atrophied areas. Conclusion results strongly suggest that degeneration occurs could impairment cognitive functions. Imaging neurons used here effective identifying potential treatment responders.

参考文章(40)
W. Gsell, I. Strein, P. Riederer, The neurochemistry of Alzheimer type, vascular type and mixed type dementias compared Journal of Neural Transmission Supplement. ,vol. 47, pp. 73- 101 ,(1996) , 10.1007/978-3-7091-6892-9_5
David L. Gildersleeve, Satoshi Minoshima, Jeffrey A. Fessler, Robert J. Ackermann, Robert A. Koeppe, Donald M. Wieland, Kirk A. Frey, Kirk A. Frey, David E. Kuhl, James E. Carey, In vivo mapping of cholinergic neurons in the human brain using SPECT and IBVM The Journal of Nuclear Medicine. ,vol. 35, pp. 405- 410 ,(1994)
H. Braak, E. Braak, Evolution of neuronal changes in the course of Alzheimer’s disease Journal of Neural Transmission. Supplementa. ,vol. 53, pp. 127- 140 ,(1998) , 10.1007/978-3-7091-6467-9_11
Elaine K. Perry, Robert H. Perry, Neurochemistry of consciousness: cholinergic pathologies in the human brain. Progress in Brain Research. ,vol. 145, pp. 287- 299 ,(2004) , 10.1016/S0079-6123(03)45020-6
Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh, “Mini-mental state” Journal of Psychiatric Research. ,vol. 12, pp. 189- 198 ,(1975) , 10.1016/0022-3956(75)90026-6
Yong-Woon Jung, Kirk A. Frey, G. Keith Mulholland, Renato del Rosario, Phillip S. Sherman, David M. Raffel, Marcian E. Van Dort, David E. Kuhl, David L. Gildersleeve, Donald M. Wieland, Vesamicol receptor mapping of brain cholinergic neurons with radioiodine-labeled positional isomers of benzovesamicol. Journal of Medicinal Chemistry. ,vol. 39, pp. 3331- 3342 ,(1996) , 10.1021/JM9507486
O. Almkvist, V. Jelic, K. Amberla, E. Hellström-Lindahl, L. Meurling, A. Nordberg, Responder characteristics to a single oral dose of cholinesterase inhibitor: a double-blind placebo-controlled study with tacrine in Alzheimer patients. Dementia and Geriatric Cognitive Disorders. ,vol. 12, pp. 22- 32 ,(2001) , 10.1159/000051232
Steven T. DeKosky, Milos D. Ikonomovic, Scot D. Styren, Laurel Beckett, Stephen Wisniewski, David A. Bennett, Elizabeth J. Cochran, Jeffrey H. Kordower, Elliott J. Mufson, Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Annals of Neurology. ,vol. 51, pp. 145- 155 ,(2002) , 10.1002/ANA.10069
Ahmadul Kadir, Taher Darreh-Shori, Ove Almkvist, Anders Wall, Bengt Långström, Agneta Nordberg, Changes in brain 11C–nicotine binding sites in patients with mild Alzheimer’s disease following rivastigmine treatment as assessed by PET Psychopharmacology. ,vol. 191, pp. 1005- 1014 ,(2007) , 10.1007/S00213-007-0725-Z
Martin R. Farlow, Jeffrey L. Cummings, Effective pharmacologic management of Alzheimer's disease. The American Journal of Medicine. ,vol. 120, pp. 388- 397 ,(2007) , 10.1016/J.AMJMED.2006.08.036